Resources

Cardiopulmonary Consequences of Vaping in Adolescents: A Scientific Statement From the American Heart Association
Cardiovascular Consequences of Childhood Secondhand Tobacco Smoke Exposure: Prevailing Evidence, Burden, and Racial and Socioeconomic Disparities: A Scientific Statement From the American Heart Association
Electronic Cigarettes: A Policy Statement From the American Heart Association
E-Cigarettes and Cardiopulmonary Health
E-Cigarettes and Cardiopulmonary Health: Review for Clinicians
Surgeon General’s Reports on Smoking and Tobacco Use
Cannabis Research Considerations

Cardiovascular and Cerebrovascular Disease

Support innovative, timely and high impact research that addresses basic, translational, or clinical aspects of cardiovascular disease (CVD) and cerebrovascular accident (CVA). Research into the mechanisms, diagnosis, prevention, and treatment of diseases resulting from the use of commercial tobacco products, with a focus on disproportionately affected groups, is of critical importance to reducing the negative impact of tobacco product use.

Examples of relevant research topics:

Studies of biological samples from users of new and emerging tobacco products to determine whether subclinical markers of CVD and cerebrovascular accident (CVA) are altered.
Interrogation of longitudinal health studies of priority populations such as the Jackson Heart Study to better understand the intersection of social determinants of health, tobacco use and heart disease.
The intersection of the effects of tobacco product use with chronic stressors and other social determinants of health on cardiovascular health or stroke risk.
The extent to which interventions that promote positive psychosocial assets (optimism, resilience, purpose in life) may promote both tobacco cessation and improved cardiovascular or cerebrovascular health.